Evidence map›Paper›PMID 39202682›Full record

ReviewLife (Basel, Switzerland)2024

Applications of the Microalgae

María J Torres, Carmen M Bellido-Pedraza, Angel Llamas

Abstract readReview
In one paragraph

Review in Life (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Microalgae Biotechnology: Methods and Applications.Bioengineering (Basel, Switzerland) · 2024
    Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

María J TorresDepartment of Biochemistry and Molecular Biology, Campus de Rabanales and Campus Internacional de Excelencia Agroalimentario (CeiA3), Edif. Severo Ochoa, University of Córdoba, 14071 Córdoba, Spain.ORCID 0000-0003-0706-7833
Carmen M Bellido-PedrazaDepartment of Biochemistry and Molecular Biology, Campus de Rabanales and Campus Internacional de Excelencia Agroalimentario (CeiA3), Edif. Severo Ochoa, University of Córdoba, 14071 Córdoba, Spain.ORCID 0000-0001-9422-1936
Angel LlamasDepartment of Biochemistry and Molecular Biology, Campus de Rabanales and Campus Internacional de Excelencia Agroalimentario (CeiA3), Edif. Severo Ochoa, University of Córdoba, 14071 Córdoba, Spain.ORCID 0000-0001-6042-9472

Funding

Junta de Andalucía Grant ProyExcel_00483Ministerio de Ciencia, Innovación y Universidades PID2020-118398GB-I00
6 · The paper itself

Abstract

The wide metabolic diversity of microalgae, their fast growth rates, and low-cost production make these organisms highly promising resources for a variety of biotechnological applications, addressing critical needs in industry, agriculture, and medicine. The use of microalgae in consortia with bacteria is proving valuable in several areas of biotechnology, including the treatment of various types of wastewater, the production of biofertilizers, and the extraction of various products from their biomass. The monoculture of the microalga

Indexed as

algal–microbial consortiabiofertilizationbioremediationChlamydomonashigh-value added productsmicroalga

Identifiers

PMID39202682
PMCPMC11355400

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.